Table 1 Patient characteristics
EQ-5D | Â | N | Mean | Â | % at level 1/2/3* |
|---|---|---|---|---|---|
Multiple Myeloma population (pooled) | Â | Â | Â | ||
Age (range) | Â | 652 | 54 (37 - 65) | Â | Â |
EQ-5D | Mobility | Â | Â | Â | 56,7/41,4/1,9 |
| Â | Self-care | Â | Â | Â | 85,8/12,8/1,4 |
| Â | Usual activities | Â | Â | Â | 30,1/51,1/18,8 |
| Â | Pain/Discomfort | Â | Â | Â | 39,6/59/1,4 |
| Â | Depression/Anxiety | Â | Â | Â | 69,4/29,6/1,0 |
| Â | EQ-5 D utility (UK tariff) | Â | ,69 (-,32 - 1) | Â | Â |
Male/Female | Â | 381/252 | Â | Â | Â |
Follow-up series | Â | t = 0, 1, 2, 3, 4, 5, 6, 7 | Â | Â | Â |
Non-Hodgkin population (pooled) | Â | Â | Â | ||
Age (range) | Â | 789 | 72 (65 - 84) | Â | Â |
EQ-5D | Mobility | Â | Â | Â | 48/47,3/4,7 |
| Â | Self-care | Â | Â | Â | 81,4/13,9/4,7 |
| Â | Usual activities | Â | Â | Â | 38,1/43,3/18,6 |
| Â | Pain/Discomfort | Â | Â | Â | 52,2/42,9/4,9 |
| Â | Depression/Anxiety | Â | Â | Â | 70/29/1,0 |
| Â | EQ-5 D utility (UK tariff) | Â | ,68 (-,59 - 1) | Â | Â |
Male/Female | Â | 480/351 | Â | Â | Â |
Follow-up series | Â | t = 0, 1, 2, 3, 4, 5, 6, 7, 8 | Â | Â | Â |
Arthritis population | Â | Â | Â | ||
Age (range) | Â | 457 | 50 (16 - 88) | Â | Â |
EQ-5D | Mobility | Â | Â | Â | 58,5/41,5/0 |
| Â | Self-care | Â | Â | Â | 75,3/24,3/,4 |
| Â | Usual activities | Â | Â | Â | 37,1/58,2/4,7 |
| Â | Pain/Discomfort | Â | Â | Â | 9/77,4/13,6 |
| Â | Depression/Anxiety | Â | Â | Â | 70,7/27,1/2,2 |
| Â | EQ5 D utility (UK tariff) | Â | ,62 (-,24 - 1) | Â | Â |
Male/Female | Â | 133/333 | Â | Â | Â |
Follow-up series | Â | t = 0 | Â | Â | Â |
Condition specific instruments | Â | Â | Â | Â | Â |
EORTC QLQ-C30 (Sum scores) | Â | Â | HAQ (Domain scores) | ||
| Â | MM population mean (SD) | NH Population mean (SD) | Arthritis population mean (SD) | ||
Physical functioning | 64 (24,6) | Â | 57,3 (26,8) | Dressing & Grooming | 0,58 (,71) |
Role functioning | 59,5 (28,9) | Â | 57,4 (31,5) | Arising | 0,65 (,73) |
Emotional functioning | 82,8 (18,9) | Â | 81,3 (20,6) | Eating | 0,75 (,82) |
Cognitive functioning | 82 (20,8) | Â | 81,9 (23,7) | Walking | 0,54 (,78) |
Social functioning | 76,2 (25,8) | Â | 75,7 (28,6) | Hygiene | 0,64 (,81) |
Global health | 68,7 (18,0) | Â | 62 (21,7) | Reach | 0,64 (,75) |
Fatigue | 35,7 (25,0) | Â | 44,7 (44,7) | Grip | 0,78 (,85) |
Nausea/Vomiting | 6,1 (14,3) | Â | 8 (16,9) | Activities | 0,94 (,88) |
Pain | 25,2 (24,7) | Â | 18,7 (26,2) | Â | Â |
Dyspnoea | 16,1 (24,9) | Â | 24,8 (28,9) | Â | Â |
Sleep | 21,1 (27,3) | Â | 28,7 (31,8) | Â | Â |
Appetite | 16 (27,2) | Â | 21,9 (32,6) | Â | Â |
Constipation | 4 (15,4) | Â | 11,8 (22,8) | Â | Â |
Diarrhea | 8,3 (18,7) | Â | 7 (18,5) | Â | Â |
Financial difficulties | 12,5 (23,0) | Â | 6,3 (16,9) | Â | Â |